MATTIELLO, Luigi
 Distribuzione geografica
Continente #
NA - Nord America 1.781
EU - Europa 1.395
AS - Asia 851
AF - Africa 17
OC - Oceania 6
SA - Sud America 5
Totale 4.055
Nazione #
US - Stati Uniti d'America 1.750
CN - Cina 482
IE - Irlanda 248
UA - Ucraina 206
SG - Singapore 197
FI - Finlandia 182
DE - Germania 179
IT - Italia 151
KR - Corea 131
SE - Svezia 128
FR - Francia 121
GB - Regno Unito 71
PL - Polonia 50
AT - Austria 33
CA - Canada 27
VN - Vietnam 21
SN - Senegal 15
GR - Grecia 9
BE - Belgio 8
IN - India 7
JP - Giappone 5
BR - Brasile 4
MX - Messico 4
FJ - Figi 3
ID - Indonesia 3
IR - Iran 3
AU - Australia 2
CH - Svizzera 2
ES - Italia 2
RU - Federazione Russa 2
CL - Cile 1
DK - Danimarca 1
HK - Hong Kong 1
MU - Mauritius 1
NL - Olanda 1
NZ - Nuova Zelanda 1
SI - Slovenia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 4.055
Città #
Beijing 392
Dublin 247
Chandler 221
Singapore 161
Jacksonville 135
Medford 103
Villeurbanne 99
Princeton 94
Ann Arbor 87
Wilmington 84
Torino 70
Dearborn 69
Nyköping 67
Houston 62
Fairfield 51
Fremont 51
Ashburn 50
Warsaw 49
Boston 34
Vienna 33
Santa Clara 30
Milan 28
New York 21
Lachine 20
Woodbridge 19
Dong Ket 17
Verona 16
Norwalk 15
Guangzhou 13
Seattle 11
Cambridge 10
Falls Church 10
Hefei 10
Kunming 10
Athens 9
Philadelphia 9
Brussels 8
Nanjing 8
Pisa 8
Boardman 7
Munich 7
Nanchang 6
Pasadena 6
Toronto 6
Pune 5
Shanghai 5
Shenyang 5
Monmouth Junction 4
Redwood City 4
Detroit 3
Jakarta 3
Jinan 3
Wenzhou 3
Wuhan 3
Xian 3
Zhengzhou 3
Ardabil 2
Bellinzago Novarese 2
Düsseldorf 2
Fuzhou 2
Helsinki 2
Kharkiv 2
Nuremberg 2
Phoenixville 2
Shaoxing 2
Silver Spring 2
Turin 2
Vestignè 2
Atlanta 1
Auburn Hills 1
Auckland 1
Aurora 1
Baltimore 1
Birmingham 1
Bologna 1
Brooklyn 1
Buffalo 1
Cavallermaggiore 1
Chengdu 1
Chongqing 1
Columbia 1
Copenhagen 1
Denver 1
Durham 1
Genova 1
Haikou 1
Hanoi 1
Hebei 1
Hong Kong 1
Huzhou 1
Jinhua 1
Kilcock 1
Langfang 1
Lausanne 1
Leawood 1
Ljubljana 1
Modena 1
Mumbai 1
Napoli 1
Ningbo 1
Totale 2.563
Nome #
NPY-Y1 coexpressed with NPY-Y5 receptors modulate anxiety but not mild social stress response in mice 181
High glucose reduces the anti-aggregating effect of aspirin by impairing the aspirin-induced activation of the nitric oxide/cGMP/PKG pathway. 120
A short-term incubation with high glucose impairs VASP phosphorylation at serine 239 in response to the nitric oxide/cGMP pathway in vascular smooth muscle cells: role of oxidative stress. 115
Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance 79
High glucose reduces the anti-aggreganting effect of aspirin by impairing the aspirin-induced activation of the nitric oxide/cGMP/PKG pathway. 79
Aspirin resistant subjects present a proinflammatory milieu with an increased oxidative stress: in these conditions, high glucose fails to influence platelet responses to agonists. 76
In Central Obesity, Weight Loss Restores Platelet Sensitivity to Nitric Oxide and Prostacyclin 76
Effects of high glucose on vascular endothelial growth factor synthesis and secretion in aortic vascular smooth muscle cells from obese and lean zucker rats. 74
GLP-1 reduces the activation of PI3K and MAPK pathways and of oxidative stress induced by Na-arachidonate in platelets. 74
High Glucose Inhibits the Aspirin-Induced Activation of the Nitric Oxide/cGMP/cGMP-Dependent Protein Kinase Pathway and Does Not Affect the Aspirin-Induced Inhibition of Thromboxane Synthesis in Human Platelets. 71
Glucagon-Like Peptide 1 reduces platelet activation: effects on PI-3K and MAPK pathways and oxidative stress in the presence of arachidonic acid. 70
Insulin activates hypoxia-inducible factor-1alpha in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways: impairment in insulin resistance owing to defects in insulin signalling 69
Effect of dopamine on adenosine 3',5'-cyclic monophosphate levels in human platelets. 67
Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect. 65
C-reactive protein increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells 63
Nitric oxide activates PI3-K and MAPK signalling pathways in human and rat vascular smooth muscle cells: influence of insulin resistance and oxidative stress. 62
Il miglioramento del controllo glicemico riduce la resistenza piastrinica all'aspirina nei pazienti affetti da diabete di tipo 2 62
Comparison between the effects of the rapid recombinant insulin analog aspart and those of human regular insulin on platelet cyclic nucleotides and aggregation. 61
Insulin influences the nitric oxide cyclic nucleotide pathway in cultured human smooth muscle cells from corpus cavernosum by rapidly activating a constitutive nitric oxide synthase. 60
Sodium azide, a bacteriostatic preservative contained in commercially available laboratory reagents, influences the responses of human platelets via the cGMP/PKG/VASP pathway. 59
L'acido oleico incrementa trascrizione, sintesi e secrezione del VEGF in cellule muscolari lisce vascolari aortiche: ridotto effetto in condizioni di insulino-resistenza 59
Resistance to the GLP-1 effects on platelets in type 2 diabetes mellitus 59
Arginine vasopressin release from human platelets after irreversible aggregation. 58
Role of NMDA receptor in homocysteine-induced activation of Mitogen-Activated Protein Kinase and Phosphatidyl Inositol 3-Kinase pathways in cultured human vascular smooth muscle cells 57
A Platelet Defect Characterised by Absent Adrenaline-induced Aggregation and Lack of Secondary Aggregation in Response to ADP and Platelet-activating Factor. 57
Impairment of GLP-1 effects in platelets from subjects affected by type 2 diabetes mellitus 57
Glucagon-Like Peptide 1 reduces platelet activation induced by sodium arachidonate through the inhibition of PI-3K and MAPK pathways. 56
Effects of diltiazem on thromboxane B2 production from platelet-rich plasma and whole blood 55
Calcium-channel blocking agents verapamil and diltiazem are inhibitors of vasopressin-induced human platelet activation. 54
Catecholamines, via beta-adrenoceptors, increase intracellular concentrations of 3',5'-cyclic guanosine monophosphate (cGMP) through nitric oxide in human platelets. 53
Effects of forskolin and organic nitrate on aggregation and intracellular cyclic nucleotide content in human platelets. 52
A comparison of the predictive power for overall blood glucose control of a 'good' fasting level in type 2 diabetic patients on diet alone or with oral agents 52
GLP-1 influences the inhibitory effects of nitric oxide on platelets. 52
Resistance to the GLP-1 effects on platelets in type 2 diabetes mellitus. 52
A short-term improvement of blood glucose control increases aspirin sensitivity in aspirin-resistant type 2 diabetic men. 51
Influence of oleic acid on vascular endothelial growth factor synthesis and secretion in aortic vascular smooth muscle cells: signalling molecules involved and role of insulin resistance 51
Oleic acid increases synthesis and secretion of VEGF in rat vascular smooth muscle cells: role of oxidative stress and impairment in obesity. 50
N-acetyl-L-cysteine exerts direct anti-aggregating effect on human platelets. 49
High glucose rapidly activates the nitric oxide/cyclic nucleotide pathway in human platelets via an osmotic mechanism 49
Acido oleico e regolazione del VEGF in cellule muscolari lisce vascolari aortiche in condizioni di insulino-sensibilità e insulino-resistenza. 49
GLP-1 and liraglutide increase the platelet inhibitory effects of nitric oxide. 48
An intensive control of blood glucose improves platelet sensitivity to aspirin in type 2 diabetes mellitus. 47
Studies on in vitro effect of picotamide on human platelet aggregation in platelet-rich plasma and whole blood. 46
Studies on inhibition of human platelet function by sodium nitroprusside. Kinetic evaluation of the effect on aggregation and cyclic nucleotide content. 45
Platelet resistance to the antiaggregating effect of N-acetyl-L-cysteine in obese, insulin-resistant subjects. 45
Il GLP-1 aumenta l'effetto inibitorio dell'ossido nitrico sulle piastrine con meccanismo GLP-1R indipendente. 45
Insulin increases cyclic nucleotide content in human vascular smooth muscle cells: a mechanism potentially involved in insulin-induced modulation of vascular tone. 44
The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents 43
Intrahepatic exIntrahepatic expression of c-fos, c-myb and c-myc oncogenes: correlation with virus-induced chronic liver disease and response to interferon. 43
Human vascular smooth muscle cells express a constitutive nitric oxide synthase that insulin rapidly activates, thus increasing guanosine 3':5'-cyclic monophosphate and adenosine 3':5'-cyclic monophosphate concentrations. 43
Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress 43
Insulin stimulates the polymorphonuclear leukocyte chemokinesis. 42
Phenothiazines inhibit collagen-induced thromboxane B2 synthesis and increase forskolin anti-aggregating effects in human platelets. 42
Phenothiazine compounds enhance phentolamine effects on platelet aggregation and thromboxane B2 production. 41
Insulin increases guanosine-3',5'-cyclic monophosphate in human platelets. A mechanism involved in the insulin anti-aggregating effect. 40
Insulin exerts opposite effects on platelet function at physiological and supraphysiological concentrations. 40
Studies on inhibition of human platelet response by diltiazem. 40
Occurrence of low blood glucose concentrations during the afternoon in type 2 (non-insulin-dependent) diabetic patients on oral hypoglycaemic agents: importance of blood glucose monitoring. 40
Desensitization of the platelet aggregation response to adrenaline during insulin-induced hypoglycaemia in man. 40
Insulin influences the renin-angiotensin-aldosterone system in humans. 40
Pancreatic elastase-1 in stools, a marker of exocrine pancreas function, correlates with both residual beta-cell secretion and metabolic control in type 1 diabetic subjects 39
Homocysteine rapidly increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. Role of phosphatidyl inositol 3-kinase and mitogen activated protein kinase pathways 39
Influenza dell’alto glucosio sull’aggregazione piastrinica in soggetti aspirino-trattati. 39
Insulin, at physiological concentrations, enhances the polymorphonuclear leukocyte chemotactic properties. 38
Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic monophosphate and adenosine-3', 5'-cyclic monophosphate 38
Interplay between milrinone and adenosine in the inhibition of human platelet response. 38
Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM. 37
Non-HDL cholesterol is a determinant of aspirin-resistance in type 2 diabetes mellitus. 37
Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost 36
Insulin-induced hypoglycaemia increases plasma concentrations of angiotensin II and does not modify atrial natriuretic polypeptide secretion in man. 36
Nonenzymatic glycation of fibronectin impairs adhesive and proliferative properties of human vascular smooth muscle cells. 35
The insulin-induced increase of guanosine-3',5'-cyclic monophosphate in human platelets is mediated by nitric oxide. 35
Studies on the effect of dopamine on the human platelet response. 35
Influence of protamine on adhesion, chemotaxis and proliferation of human vascular smooth muscle cells. 34
Insulin influences immunoreactive endothelin release by human vascular smooth muscle cells. 33
Modulation of human platelet function by L-canavanine. Differentail effects of low and high concentrations 33
L-arginine modulates aggregation and intracellular cyclic 3',5'-guanosine monophosphate levels in human platelets: direct effect and interplay with antioxidative agent. 32
Glyceryl trinitrate enhances the adenosine-induced inhibition of platelet responses: a mechanism potentially involved in the in vivo anti-aggregating effects of organic nitrates. 32
Moderate exercise increases platelet function in type I diabetic patients without severe angiopathy and in good control. 30
Impaired insulin-induced platelet anti-aggregating effect in obesity and in obese non-insulin-dependent diabetes mellitus 30
Impaired synthesis and action of antiaggregating cyclic nucleotides in platelets from obese subjects: possible role in platelet hyperactivation in obesity 30
Studies on the influence of insulin on cyclic adenosine monophosphate in human vascular smooth muscle cells: dependence on cyclic guanosine monophosphate and modulation of catecholamine effects. 29
Totale 4.277
Categoria #
all - tutte 14.888
article - articoli 0
book - libri 0
conference - conferenze 4.080
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.968


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020478 0 0 0 52 57 97 83 20 74 50 27 18
2020/2021357 51 23 47 11 17 8 28 1 89 39 14 29
2021/2022471 13 9 8 10 8 6 13 19 11 37 154 183
2022/2023760 105 52 22 30 72 249 86 41 66 15 19 3
2023/2024280 29 61 10 18 18 47 1 2 0 7 24 63
2024/2025227 2 173 43 9 0 0 0 0 0 0 0 0
Totale 4.277